PolyPeptide Group AG (SWX:PPGN)
Switzerland · Delayed Price · Currency is CHF 43.95
0.00 (0.00%)
Aug 21, 2026, 5:31 PM CET
PolyPeptide Group AG Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 458.86 | 389.33 | 336.79 | 320.37 | 280.98 | 282.13 |
| 458.86 | 389.33 | 336.79 | 320.37 | 280.98 | 282.13 | |
Revenue Growth | 24.40% | 15.60% | 5.13% | 14.02% | -0.41% | 25.78% |
Cost of Revenue | 353.95 | 324.04 | 299.31 | 315.6 | 228.99 | 182.43 |
Gross Profit | 104.91 | 65.29 | 37.49 | 4.77 | 51.99 | 99.7 |
Selling, General & Admin | 68.68 | 55.64 | 44.25 | 41.54 | 40.63 | 32.5 |
Research & Development | 2.93 | 2.28 | 1.1 | 1.47 | 1.24 | 1.41 |
Other Operating Expenses | -10.87 | -1.11 | -1.9 | -4.4 | -2.41 | -1.61 |
Operating Expenses | 60.74 | 56.82 | 43.44 | 38.6 | 39.46 | 32.3 |
Operating Income | 44.17 | 8.47 | -5.95 | -33.83 | 12.53 | 67.4 |
Interest Expense | -10.61 | -17.2 | -13.85 | -5.62 | -2.09 | -2.82 |
Interest & Investment Income | 4.75 | 1.82 | 0.59 | 0.05 | 0.01 | 0.01 |
Currency Exchange Gain (Loss) | -12.27 | -12.27 | 6.18 | -14.5 | -1.63 | -1.87 |
Other Non Operating Income (Expenses) | -1.02 | -1.02 | -3.63 | -1.63 | -1.25 | -0.17 |
EBT Excluding Unusual Items | 25.02 | -20.2 | -16.66 | -55.52 | 7.57 | 62.55 |
Gain (Loss) on Sale of Assets | 1.44 | 1.44 | - | - | - | - |
Asset Writedown | -1.3 | -1.3 | -1.49 | -2.72 | - | - |
Other Unusual Items | - | - | - | - | - | -2.71 |
Pretax Income | 25.16 | -20.06 | -18.15 | -58.24 | 7.57 | 59.85 |
Income Tax Expense | 10.71 | 1.11 | 1.42 | -6.8 | -0.2 | 12.59 |
Net Income | 14.45 | -21.17 | -19.56 | -51.44 | 7.77 | 47.26 |
Net Income to Common | 14.45 | -21.17 | -19.56 | -51.44 | 7.77 | 47.26 |
Net Income Growth | - | - | - | - | -83.56% | 50.81% |
Shares Outstanding (Basic) | 33 | 33 | 33 | 33 | 33 | 32 |
Shares Outstanding (Diluted) | 33 | 33 | 33 | 33 | 33 | 32 |
Shares Change | -1.93% | 0.09% | 0.10% | -0.11% | 2.74% | 7.08% |
EPS (Basic) | 0.44 | -0.64 | -0.59 | -1.56 | 0.24 | 1.47 |
EPS (Diluted) | 0.44 | -0.64 | -0.59 | -1.56 | 0.24 | 1.47 |
EPS Growth | - | - | - | - | -83.98% | 41.35% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -49.72 | -30.24 | 3.65 | -16.41 | -69.64 | -16.61 |
Free Cash Flow Per Share | -1.52 | -0.92 | 0.11 | -0.50 | -2.11 | -0.52 |
Dividend Per Share | - | - | - | - | - | 0.289 |
Dividend Growth | - | - | - | - | - | - |
Gross Margin | 22.86% | 16.77% | 11.13% | 1.49% | 18.50% | 35.34% |
Operating Margin | 9.63% | 2.18% | -1.77% | -10.56% | 4.46% | 23.89% |
Profit Margin | 3.15% | -5.44% | -5.81% | -16.06% | 2.76% | 16.75% |
Free Cash Flow Margin | -10.83% | -7.77% | 1.08% | -5.12% | -24.79% | -5.89% |
EBITDA | 75.45 | 38.1 | 18.28 | -12.31 | 33.05 | 83.46 |
EBITDA Margin | 16.44% | 9.79% | 5.43% | -3.84% | 11.76% | 29.58% |
D&A For EBITDA | 31.28 | 29.63 | 24.23 | 21.52 | 20.53 | 16.06 |
EBIT | 44.17 | 8.47 | -5.95 | -33.83 | 12.53 | 67.4 |
EBIT Margin | 9.63% | 2.18% | -1.77% | -10.56% | 4.46% | 23.89% |
Effective Tax Rate | 42.56% | - | - | - | - | 21.04% |
Revenue as Reported | 471.25 | 391.95 | 338.77 | 324.85 | 283.46 | 286.22 |